Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer

ABSTRACT: The overall objective of these studies are to confirm that ctDNA detected in plasma after intended curative treatment for CRC can be applied in clinical practice as a marker of subclinical residual disease and risk of recurrence.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2281569 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR